« Previous 12345 Next »
Viewing Page 1 of 5 | Showing Results 1 - 10 of 50

Combination immunotherapy study for renal cancer at Providence Cancer Institute

July 17, 2019

T-cell checkpoint antibodies have revolutionized immunotherapy for cancer, including renal cancer. At Providence Cancer Institute, several clinical trials of these novel approaches are now open to patients with renal cell carcinoma (RCC), including a new phase III study evaluating the effectiveness of checkpoint immunotherapy in combination with an investigational cytokine agent, compared to standard-of-care targeted therapy.

Can adjuvant immunotherapy prevent recurrence of high-risk cutaneous squamous cell carcinoma?

June 25, 2019

A new phase 3 study open at the Earle A. Chiles Research Institute, a division of Providence Cancer Institute in the Robert W. Franz Cancer Center, will evaluate the curative potential of adjuvant pembrolizumab in patients with high-risk or locally-advanced cutaneous squamous cell carcinoma (LA cSCC).

Cancer Survivor Challenges Providence Immunotherapy Researchers and Benefactors "Your Work is not Done" - Community Responds with Record Breaking Fundraising Night

June 14, 2019

In a matter of minutes William Kennedy went from explaining how unfortunate he is – with his diagnosis of incurable cancer – to how fortunate he is – finding Providence and hope. He told the attendees at the 2019 Providence Creating Hope Dinner that time is now truly a gift – and they can give him, and others fighting cancer, more time by giving generously to research.

New chemoimmunotherapy study for lung cancer

May 28, 2019

In the last year, the combination of pembrolizumab (Keytruda) with chemotherapy has become a frontline treatment for people with metastatic non-small cell lung cancer (NSCLC). The FDA granted full approval for the combination treatment last August based on studies that showed a clear survival benefit over chemotherapy alone.

New study for metastatic breast cancer focuses on immunotherapy combination

April 22, 2019

A newly opened study for metastatic HER2-negative breast cancer will evaluate an alternative systemic treatment combination that omits or delays the use of chemotherapy while improving the efficacy and durability of response.

Providence researcher plays key role in NASA twins study

April 17, 2019

Identical twin astronauts – one grounded on Earth and the other launched into space – proved to be fascinating research subjects for Providence genomics expert and cancer researcher Brian Piening, Ph.D., who helped NASA explore the effects of long-term space missions on the body. Dr. Piening now uses what he learned to personalize treatment for cancer patients at Providence.

Breast cancer immunotherapy breakthrough

April 03, 2019

Providence Cancer Institute’s commitment to advancing immunotherapy research and clinical trials is, again, making a difference in the lives of cancer patients at home and around the world.

A new approach for recurrent head/neck cancer

March 25, 2019

The light-activated drug ASP-1929 is showing promise as a potential new treatment for people with recurrent head and neck cancers. A new study of this first-in-class, precision targeted therapy is opening soon at Providence Cancer Institute.

Phase 1 trials advance promising new immunotherapies for cancer

March 01, 2019

Phase 1 studies are the springboard for advancing new cancer treatments. Through phase 1 studies, the Earle A. Chiles Research Institute, a division of Providence Cancer Institute in the Robert W. Franz Cancer Center, is often able to offer patients first-in-human clinical trials of immunotherapies and other novel cancer therapies, including these two recently opened studies.

Immunotherapy studies open for triple-negative breast cancer

January 22, 2019

Emerging research is finding that immunotherapy may extend survival for some women with triple-negative breast cancer. Providence Cancer Institute, a leader in immunotherapy research, is actively investigating options for this aggressive cancer.

« Previous 12345 Next »
Viewing Page 1 of 5 | Showing Results 1 - 10 of 50